Literature DB >> 18211224

If it's broken, shouldn't it be fixed? Informed consent and initial clinical trials of gene therapy.

Arthur L Caplan1.   

Abstract

Mesh：

Year:  2008        PMID： 18211224     DOI： 10.1089/hum.2007.1010

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  4 in total

1.  When ethics constrains clinical research: trial design of control arms in "greater than minimal risk" pediatric trials.

Authors:  Inmaculada de Melo-Martín; Dolan Sondhi; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2011-05-19       Impact factor: 5.695

2.  A call for physiopathological ethics.

Authors:  Pedro R Lowenstein
Journal:  Mol Ther       Date:  2008-11       Impact factor: 11.454

Review 3.  Accepting risk in clinical research: is the gene therapy field becoming too risk-averse?

Authors:  Claire T Deakin; Ian E Alexander; Ian Kerridge
Journal:  Mol Ther       Date:  2009-09-22       Impact factor: 11.454

Review 4.  Clinical trials in gene therapy: ethics of informed consent and the future of experimental medicine.

Authors:  Pedro R Lowenstein
Journal:  Curr Opin Mol Ther       Date:  2008-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.